| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |